Jaguar Health (JAGX) Research & Development (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Research & Development data on file, last reported at $896000.0 in Q1 2026.

• On a quarterly basis, Research & Development fell 64.06% year-over-year to $896000.0 in Q1 2026; TTM through Mar 2026 was $22.1 million, a 491.13% increase from a year earlier, with the FY2025 full-year figure at $25.0 million, up 224.57% from the prior year.
• Research & Development for Q1 2026 stood at $896000.0, down from $14.3 million in the prior quarter.
• Over the last five years, Research & Development for JAGX reached as high as $14.3 million in Q4 2025 and fell as low as -$8.7 million in Q4 2023.
• Historically, Research & Development has averaged $2.8 million across 5 years, with a median of $3.3 million in 2025.
• Across the five-year window, Research & Development slumped 301.18% in 2023 and soared 431.63% in 2025, its largest moves.
• Year by year, Research & Development stood at $4.3 million in 2022, then tumbled by 301.18% to -$8.7 million in 2023, then surged by 50.24% to -$4.3 million in 2024, then surged by 431.63% to $14.3 million in 2025, then slumped by 93.74% to $896000.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $896000.0 in Q1 2026, $14.3 million in Q4 2025, and $3.7 million in Q3 2025.